Titolo/oggetto del contratto di sperimentazione
A Phase 3, open label, Multi-center, randomized study evaluating the efficacy of TAR 200 in combination with cetrelimab versus concurrentchemo-radiotherapy in partecipants with muscle invasive urothelial carcinoma receiving radical cystectomy